Director Of Process Development, Head Of Analytical Sciences, Bioassay, And Qc
CurrentLead CMC activities supporting Aptevo’s clinical development of ADAPTIR™ (bispecific antibodies) therapeutic candidates for hematologic and solid tumor indications. Guide development of phase appropriate manufacturing processes, analytical methods, and potency assays for pre-clinical therapeutic candidates. Transfer these processes and methodologies to.